قائمة الدراسات السريرية المسجلة على الادوية

عنوان الدراسة	داعم الدراسة	حالة الدراسة	دواء الدراسة	مرحلة الدراسة	رقم بروتوكول الدراسة	موقع الدراسة
Randomized, three- way, three- period, single oral dose, open-label, crossover, bioequivalence study to compare Lorvast Tablets /Tabuk Pharmaceutical Mfg. Co. (20 mg Atorvastatin), versus Lipitor® (20 mg Atorvastatin) Produced by Pfizer in healthy subjects under fasting conditions.	SFDA	Completed	Lipitor® lovarst tablet	4	42370	saudi Ajal
SAUDI ARABIA – A DISEASE REGISTRY STUDY TO PROSPECTIVELY OBSERVE TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH HER2-POSITIVE UNRESECTABLE LOCALLY ADVANCED OR METASTATIC BREAST CANCER	Roche	Ongoing	N/A	4	ML29618	King Abdulaziz Medical City NG (Riyadh)
Treatment Patterns, Outcomes, and Resource Use Study For Advanced Stage Non-Small Cell Lung Cancer (Squamous and Non-Squamous)in Kingdom of Saudi Arabia and United Arab Emirates	Bristol-Myers Squibb	Ongoing	-	4	CA209454	King Abdulaziz Medical City NG (Riyadh)
The study of efficacy and saftey of Rituximab in treatment of resistant glomerulonephritis	The Saudi center for Organ Transplantation (SCOT)	Ongoing	Rituximab	3	MN-101-11	King Fahad Medical City (Riyadh), King Abdulaziz Hospital and Oncology Center (Jeddah), Dammam Medical Complex, King Fahad Hospital (Jeddah), Armed Forces Hospital  (Al-Hada), Armed Forces Hospital (Southern Region), King Fahad University Hospital (Al-Khobar), King Fahd Armed Forces Hospital (Jeddah)
Phase III, Double-Blind, Placebo-Controlled Study Of Post-Operative Adjuvant Concurrent Chemo-Radiotherapy With Or Without Nimotuzumab For Stage III/IV Head And Neck Squamous Cell Cancer	King Fahad Medical City	Ongoing	Nimotuzumab	3	1HN01	King Fahad Medical City (Riyadh)
Treatment of Neuroendocrine Tumors (NETs) with combination of Everolimus and Radiolabeld Somatostatin Analogue	King Faisal Specialist Hospital & Research Centere	Ongoing	Everolimus	2	ONC-CRC 12- 12	King Faisal Specialist Hospital and Research Center (Riyadh)
Circulating Endotoxin as a Contributing Inflammatory Mediator in Osteoporosis Risk and its Association with Vitamin D Deficiency	National Plan for Science and Technology	Ongoing	Vitamin D3 / Alendronate	3	11-MED-2113-02	Ministry of Health
The Effect of Rectal Progesterone on the Latency period as well as Maternal and Prenatal Outcome in PPROM Between 24-33+6 Weeks	Umm Al Qura University	Ongoing	Progesterone	3	ISRCTN65694106	Umm Al Qura University, King Abdulaziz University Hospital (Jeddah), Dr. Soliman Fakeeh Hospital (Jeddah), International Medical Center (Jeddah)
Potential Benefits of Black Seed Oil Supplementation on Asthma Inflammation and Outcomes	King Abdulaziz University Hospital	Completed	Black Cumin Oil	2	95-15	King Abdulaziz University Hospital (Jeddah)
Effect of Gum Arabic supplementation on butyrate, uremic retention molecules and inflammation in chronic kidney disease patients	King Fahad Specialist Hospital - Dammam	Ongoing	Gum Arabic / E-114	2	2	King Fahad Specialist Hospital (Dammam)